Company Filing History:
Years Active: 1986-1988
Title: Christine G Collins: Innovator in Antidepressant Research
Introduction
Christine G Collins is a notable inventor based in San Jose, CA (US). She has made significant contributions to the field of antidepressant research, holding a total of 3 patents. Her work focuses on the development of innovative compounds and methods for the detection and analysis of tricyclic antidepressants.
Latest Patents
Christine's latest patents include groundbreaking advancements in the conjugation of tricyclic antidepressants to antigens and enzymes. One of her patents describes tricyclic antidepressant functionalized compounds that can be conjugated through a side chain to antigenic compounds, particularly poly(amino acids), and enzymes. These antigenic conjugates are utilized for the production of antibodies and are particularly useful in immunoassays for determining or detecting the total amount of tricyclic antidepressants present in a sample. Another significant patent involves a method for serum pretreatment in tricyclic antidepressant drug assays. This method involves passing serum through a column containing alkylated silica gel, followed by a washing process with a specific mixture to remove the tricyclic antidepressant drug from the column. This results in a drug sample that is free from interfering metabolites, making it suitable for assay determinations.
Career Highlights
Christine G Collins has been associated with Syntex (U.S.A.) Inc., where she has contributed her expertise in the field of pharmaceutical research. Her innovative approaches have led to advancements in the understanding and analysis of antidepressant compounds.
Collaborations
Throughout her career, Christine has collaborated with notable colleagues, including Marcel R Pirio and Prithipal Singh. These collaborations have further enhanced her research and development efforts in the field.
Conclusion
Christine G Collins is a pioneering inventor whose work in antidepressant research has led to significant advancements in the field. Her patents reflect her commitment to improving the detection and analysis of tricyclic antidepressants, showcasing her valuable contributions to pharmaceutical science.